City
Epaper

Healthcare sector value chain can boost Indian pharma exports: Commerce Secy

By IANS | Updated: August 29, 2024 15:35 IST

New Delhi, Aug 29 While India is already known as the 'pharmacy of the world', the country also ...

Open in App

New Delhi, Aug 29 While India is already known as the 'pharmacy of the world', the country also has huge scope to enter the global value chain system to further boost exports of pharma products, said Sunil Barthwal, Secretary, Union Ministry of Commerce and Industry on Thursday.

He said this during an interaction with pharma sector industry leaders at the ongoing three-day International Pharmaceutical Exhibition (IPHEX) jointly organised by the Pharmaceutical Export Promotion Council and the ministry.

“The Department of Commerce has included pharma as an important sector.

He added said that “the mobility chain created by the automobile industry has included all component auto linked part manufacturers including tyre, engine, brakes, steel makers and other related parts”.

This, he said, helped in increasing exports and finding new markets.

“Similarly, the pharma industry should include medical instrument manufacturers, diagnosis, hospitals, etc, and offer total packages to the world for both pre and post-health care at affordable prices. This can be done without losing the main focus of manufacturing pharma products,” the Secretary said.

He further noted that there are opportunities to increase pharmaceutical trade and provide affordable medicines and health care to many countries, including in Africa.

“Pharma should also look at emerging markets. Worldwide over including in the US, the debate is going on for moving towards affordable medicines and removing trade barriers and product patents,” Barthwal said.

He also mentioned the Free Trade Agreement (FTA) that India is signing with many countries and other measures like “stopping a fresh trial system for the US FDA-approved products”.

Removing these technical barriers can help create “a free level playing field for Indian companies as per WTO rules”, the Secretary noted.

At the IPHEX 2024, more than 400 major Indian pharma companies will showcase their pharmaceutical products and technologies at the expo. More than 400 foreign buyers from across the world are expected to attend.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

BusinessTRAI issues consultation paper to regulate sale of foreign TSPs' SIM cards meant for use in devices for exports

InternationalIndonesia: Classical Indian dance drama 'Shiva Tandava' steals the show at Bali Festival

BusinessAviva Life Insurance Wins Product of the Year 2025 in Retirement Income and ULIP Categories

BusinessVietnam eVisa for Indians: Everything You Need to Know

BusinessIndia-Spain Cultural Exchange Highlights Disability Inclusion through Film and Dialogue

Business Realted Stories

BusinessSave Earth Mission Unveils Global Vision - Announces World's Largest Plantation Drive in Over 60 Countries Starting August 2025

BusinessTata Steel gets Rs 1,902 crore demand notice from Odisha govt

BusinessJane Street can't get away in India thanks to SEBI: Nithin Kamath

BusinessIndian Potash Limited’s Dr. Parvinder Singh Gahlaut supports Krishi Vigyan Kendras

BusinessBEML unveils phase-I aerospace SEZ facility in Bengaluru